대상포진후 신경통의 약물치료
Pharmacologic Treatment of Postherpetic Neuralgia
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Abstract
Postherpetic neuralgia (PHN) is a common complication of herpes zoster, particularly in the elderly and people with severe symptoms and presentation. This reviews summarizes the published results of randomized trials involving the treatment for PHN conditions. Anticonvulsants, such as gabapentin, carbamazepine and lamotrigine, and tricyclic antidepressants, including amitriptyline and nortriptyline, have demonstrated efficacy in several studies in relieving the pain associated with PHN. However, the lack of head-to-head comparison studies of these agents has limited the conclusions that can be reached. Using quality-of-life study outcomes, treatment strategies must encompass the impact of therapeutic agents on the comorbid conditions of sleep disturbance, mood and the anxiety disorders associated with PHN. Despite these treatment advances, many patients remain refractory to current therapy, and the prevention of PHN has therefore become an important focus of current research. Looking to the future, emerging therapies, such as pregabalin and newer N-methyl-D-aspartate receptor blockers, may provide physicians and patients with new treatment options for the more effective relief of herpetic pain.
참고문헌 (27)
- Jung BF, "Risk factors for postherpetic neuralgia in patients with herpes zoster", 62, pp.1545~51 (2004)
- Bowsher D, "Factors influencing the features of postherpetic neuralgia and outcome when treated with tricyclics", 7, pp.1~7 (2003)
- Watson CP, "Postherpetic neuralgia", 2, pp.295~307 (2002)
- Dworkin RH, "Treatment and prevention of postherpetic neuralgia", 36, pp.877~82 (2003)
- Pappagallo M, "Pharmacological management of postherpetic neuralgia", 17, pp.771~80 (2003)
- Baron R, "Post-herpetic neuralgia case study:optimizing pain control", 11, pp.~11 (2004)
- Dan K, "Mechanism- based treatment of zoster-associated pain", 7, pp.157~80 (2000)
- Backonja MM, "Pharmacologic management part 1:better-studied neuropathic pain disease", 5, pp.~47 (2004)
- Dworkin RH, "Advances in neuropathic pain", diag(sis), pp.1524~34
- Gross G, "Herpes zoster guideline of the German Dermatology Society", pp.227~89
- Urban I, "Chronic neuropathic pain:pathomechanism and pharmacology", 54, pp.159~166 (2002)
- Raja SN, "Opioids versus antidepressants in postherpetic neuralgia", pp.1015~21
- Johnson RW, "Consequences and management of pain in herpes zoster", 186, pp.~90 (2002)
- Sumpton JE, "Treatment of neuropathic pain with venlafaxine", 35, pp.557~9 (2001)
- Asconape JJ, "Some common issues in the use of antiepileptic drugs", 22, pp.27~39 (2002)
- Dworkin RH, "Pregabalin for the treatment of postherpetic neuralgia", pp.1274~83
- Galvez R, "Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia results of a randomized", maiso(be p), pp.26~35
- Singh D, "The use of gabapentin for the treatment of postherpetic neuralgia", 11, pp.852~89 (2003)
- Rose MA, "Gabapentin:pharmacology and its use in pain management", 57, pp.451~62 (2002)
- Desmeules JA, "The tramadol option", 4 suppl a, pp.15~21 (2000)
- Parsons CG, "NMDA receptors as targets for drug action in neuropathic pain", 429, pp.71~8 (2001)
- Szallasi A, "Vanilloid receptor ligands:hopes and realities for the future", 18, pp.561~73 (2001)
- Davies PS, "Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia", 64, pp.937~47 (2004)
- Martin TJ, "Pharmacology of opioid and nonopioid analgesics in chronic pain states", 299, pp.811~7 (2001)
- Wu CL, "The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia", 87, pp.121~9 (2000)
- Opstelten W, "Interventions to prevent postherpetic neuralgia:cutaneous and percutaneous technique", 107, pp.202~6 (2004)
- Opstelten W, "Interventions to prevent postherpetic neuralgia:cutaneous and percutaneous technique", 107, pp.202~6 (2004)